ZP-10395

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameZP-10395
Drug Alias Nameganglioside inhibitor (Zacharon Pharmaceuticals)ganglioside inhibitors (Zacharon Pharmaceuticals)ZP-10354ZP-10295ZP-3029 +[6] 
ClassificationSmall molecules
Mechanisms of ActionGanglioside inhibitors
TargetsGanglioside
Therapy Area/IndicationsLysosomal Storage DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesZacharon Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesZacharon Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsLysosomal Storage DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A